SenesTech, Inc. (SNES) News
Filter SNES News Items
SNES News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SNES News Highlights
- SNES's 30 day story count now stands at 2.
- Over the past 8 days, the trend for SNES's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest SNES News From Around the Web
Below are the latest news stories about SenesTech Inc that investors may wish to consider to help them evaluate SNES as an investment opportunity.
We Think SenesTech (NASDAQ:SNES) Needs To Drive Business Growth CarefullyEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
SenesTech Announces 2021 Second Quarter Financial and Operational ResultsSenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest®, announced today revenues for the second quarter of 2021 increased 125% from the same period a year ago, and are up 82% sequentially. Year to date, revenues have increased 130% from the same period last year. The growth is driven by continued adoption of ContraPest across its key market segments an |
SenesTech to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its second quarter 2021, ended June 30, 2021, after the market close on Thursday, August 12, 2021. The Company has scheduled a conference call that same day, Thursday, August 12, 2021, at 5:00 pm ET, to review the results. |
3 Under the Radar Penny Stocks With Triple-Digit Gains in SightLet’s take a look away from the headline-grabbing market giants, and head into the world of penny stocks. Traditionally, these were stocks priced at just pennies per share – that’s the old English copper penny, when it was 240 pence to the pound – but nowadays the ‘pennies’ are stocks with share prices under $5. The penny stocks offer retail investors a series of advantages, all connected. Their low price makes the cost of entry to the market affordable – a relatively small investment can net a large bloc of shares. |
SenesTech to Present at the Lytham Partners Summer 2021 Investor ConferenceSenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Spring 2021 Investor Conference on Tuesday, June 15, 2021 at 11:45am ET. |
SenesTech to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its first quarter 2021, ended March 31, 2021, after the market close on Thursday, May 13, 2021. The Company has scheduled a conference call that same day, Thursday, May 13, 2021, at 5:00 pm ET, to review the results. |
SenesTech Launches New Brand and Website for ContraPest® "The Pest Control Difference"SenesTech, Inc. (NASDAQ: SNES) announced today the launch of its new brand campaign, "The Pest Control Difference" featuring ContraPest® which is revolutionizing pest management by targeting rodent reproduction. As the industry leader in fertility management, ContraPest® is bringing to pest control a highly effective and sustainable addition to integrated pest management (IPM). The rebrand represents SenesTech's evolution from a science-based research company to a solutions-based, environmentally responsible, commercial company providing a new and proven tool to pest control management for the 21st century. |
SenesTech Announces Year End 2020 Financial and Operational ResultsSenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced financial and operational results for the fourth quarter and fiscal year 2020, which ended on December 31, 2020. |
What's Happening With APTO Stock And SNES Stock Today?Aptose Biosciences Inc (NASDAQ: APTO) shares are trading higher after the company reported fourth-quarter earnings results. Oppenheimer analyst Matthew Biegler also maintains Aptose with an Outperform and raises the price target from $8 to $9. Aptose is a biotechnology company. The company develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. SenesTech Inc (NASDAQ: SNES) shares are trading higher after the company announced the initiation of a collaboration with Liphatech to develop a non-liquid formulation of ContraPest. SenesTech is a biotech platform and research company engaged in developing technology ... |
SenesTech Announces Collaboration with Liphatech to Develop a New Non-Liquid Formulation of ContraPest®SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the initiation of a collaboration with Liphatech, Inc., a global leader in the research, manufacturing and distribution of innovative pest control products, to develop a non-liquid formulation of ContraPest®. Both companies will be contributing resources to the project. |